Literature DB >> 28520529

Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma.

Maryam Babaei1,2, Khalil Abnous1, Seyed Mohammad Taghdisi3, Sara Amel Farzad2, Mohammad Taghi Peivandi4, Mohammad Ramezani1,5, Mona Alibolandi1.   

Abstract

AIM: In this study, we report the fabrication of epithelial cell adhesion molecule targeted 5-fluorouracil (5-FU) encapsulated PEGylated mesoporous silica nanoparticles (NPs) hybridized with gold NPs (PEG-Au@Si-5-FU) as gatekeeper for theranostic applications. MATERIALS &
METHODS: The prepared targeted and nontargeted formulations were evaluated in vitro in terms of their cellular internalization and toxicity. The prepared theranostic hybrid system was also implemented for computed tomography of HepG2 tumor-bearing nude mice in vivo.
RESULTS: Fluorescence microscopy and MTT assay demonstrated that the developed epithelial cell adhesion molecule-PEG-Au@Si-5-FU had higher cytotoxicity than nontargeted PEG-Au@Si-5-FU in 2D and 3D HepG2 cell cultures. Moreover, the targeted hybrid system was preferentially accumulated in HepG2 tumor cells in vitro and in vivo.
CONCLUSION: This work introduces a novel strategy for developing multimodal NPs via nanoparticulate hybrid materials.

Entities:  

Keywords:  5-fluorouracil; EpCAM; aptamer; gatekeeper; gold nanoparticles; silica

Mesh:

Substances:

Year:  2017        PMID: 28520529     DOI: 10.2217/nnm-2017-0028

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  12 in total

Review 1.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

2.  Emerging Nanotheranostics for 5-Fluorouracil in Cancer Therapy: A Systematic Review on Efficacy, Safety, and Diagnostic Capability.

Authors:  Chee Wun How; Siew Li Teoh; Jian Sheng Loh; Stella Li Kar Tan; Jhi Biau Foo; Hui Suan Ng; Stephenie Yoke Wei Wong; Yong Sze Ong
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

3.  Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.

Authors:  Seyed Mojtaba Mashmoul Moghadam; Mona Alibolandi; Maryam Babaei; Jafar Mosafer; Amir Sh Saljooghi; Mohammad Ramezani
Journal:  J Biol Inorg Chem       Date:  2020-11-06       Impact factor: 3.358

Review 4.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

Review 5.  Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.

Authors:  Anna Watermann; Juergen Brieger
Journal:  Nanomaterials (Basel)       Date:  2017-07-22       Impact factor: 5.076

6.  The Synergism of Platinum-Gold Bimetallic Nanoconjugates Enhances 5-Fluorouracil Delivery In Vitro.

Authors:  Vareessh Maney; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 7.  Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.

Authors:  Nerea Iturrioz-Rodríguez; Miguel A Correa-Duarte; Mónica L Fanarraga
Journal:  Int J Nanomedicine       Date:  2019-05-08

8.  Concept Design, Development and Preliminary Physical and Chemical Characterization of Tamoxifen-Guided-Mesoporous Silica Nanoparticles.

Authors:  Candace M Day; Martin J Sweetman; Shane M Hickey; Yunmei Song; Yongjun Liu; Na Zhang; Sally E Plush; Sanjay Garg
Journal:  Molecules       Date:  2021-01-04       Impact factor: 4.411

Review 9.  Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-05-09       Impact factor: 5.076

Review 10.  Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances.

Authors:  Yaoye Tao; Jianguo Wang; Xiao Xu
Journal:  Front Bioeng Biotechnol       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.